FeesSafety
Pluang+

Abbott shares drop over 17% in 2026, with 5-year investment losing value amid growth challenges.

Market News
21 Nov 2026, 19:35 WIB
24/7 Wall Street
View Source
Bearish
Abbott shares drop over 17% in 2026, with 5-year investment losing value amid growth challenges.

Abbott Laboratories' stock fell 17.79% in 2026, declining from $125.29 to $103.00, underperforming the S&P 500's 1.16% gain. Despite a $21 billion acquisition of Exact Sciences and plans to spin off its nutrition business, Abbott's growth slowed due to cooling glucose monitor sales and lowered sales outlook. Over five years, a $1,000 investment in Abbott shrank to about $900, trailing the S&P 500's gains. The company’s dividend increases have provided some income cushion, but future growth depends on reaccelerating glucose monitor sales and successful business restructuring.

Abbott Laboratories (ABT) trades at $103.00 on Pluang as of Nov 22, 2026 00:51 WIB, down from its 52-week high of $128.90 but well above the 52-week low of $82.57. Its dividend yield stands at 2.45%, while the typical hold time on Pluang is 96 days, with a majority of orders leaning 70% Sell versus 30% Buy. This contrasts with Abbott's recent price decline and highlights investor caution despite some income from dividends.

More News (ABT)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App